Trial Profile
A prospective clinical study of apatinib in the treatment of brain metastases from lung cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 10 Apr 2018 New trial record